Book Chapter: Medical use of cannabidiol in fragile X syndrome
Product Description:
The most recent trials of a topical CBD preparation have demonstrated significant efficacy in anxiety and in behavioral challenges for those with FXS. This chapter reviews the clinical and molecular phenotype for FXS and associated disorders and the studies utilizing CBD in patients with FXS.
Keyword(s):
fragile x syndrome, treatment, clinical trials
Product/Publication Type(s):
Book Chapter
Target Audience:
Policymakers
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A